AIFF Company Profile and Key Details

Firefly Neuroscience, Inc. generated EPS of -$2.53 over the past year. Five-year average earnings growth is 3.61%.

Short-term trend indicators are bullishly aligned (SMA20 -8.4%, SMA50 -28.01%, SMA200 -68.67%). The stock’s 14-day RSI is 33.68 (weak momentum), while the ATR of 0.06 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -88.57% below its high and over 11.98% above its low. Average 10-day trading volume of 240.33 thousand shares is below the 3-month average of 620.69 thousand, indicating normal recent market interest.

Firefly Neuroscience, Inc. has 15.57 million shares outstanding. The public float is 13.58 million shares, elevated short interest at 5.53% of float. This equals 738.85 thousand shares. The short ratio is 2.73 days. Institutional investors hold 10.95% of the float. Insiders own 28.0%.

Firefly Neuroscience, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.43. This means the shares are trading below this model’s fair value.

The stock is currently mid-range between its 52-week high and low $0.62 and $3.63. With a market capitalization of about $19.12 million, Firefly Neuroscience, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.53). Key stats such as the average daily volume over the past year has been around 620.10 thousand shares, volume is running light vs its 52-week average. Headquartered in Kenmore, ON, Firefly Neuroscience, Inc. operates in the Technology sector and the Software - Application industry. Led by CEO Greg Lipschitz, the company employs approximately 13 people and listed since November 28, 2002. Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions.

Firefly Neuroscience, Inc. trades at a P/E ratio of -1.83, slightly below the S&P 500 average, with a price-to-sales ratio of 12.27 and a price-to-book ratio of 2.39 suggesting the stock is closer to book value. The P/FCF stands at -2.49, also below market averages.

Our AI price prediction model suggests that Firefly Neuroscience, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -23.58%, with price expected at $0.94 by July 13, 2026, within a range of $0.88 to $1.00 3-Month Outlook: Projected fall of -58.54%, reaching $0.51 by September 25, 2026, with a range of $0.00 to $0.53. 1-Year Outlook: Projected loss of -3.25%, with price at $1.19 by June 29, 2027, within a range of $0.03 to $1.18.

Firefly Neuroscience, Inc. (NASDAQ:AIFF) shares are up 13.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Firefly Neuroscience, Inc. trading at a premium to the broader market with a P/E of -1.83. Our AI forecast model points to short-term weakness (-23.58% over two weeks), a medium-term fall (-58.54% over three months), and a longer-term loss (-3.25% over one year), with expected trading ranges indicating moderate volatility.